Genomic & Biopharma News

Deletion of specific enzyme leads to improvement in memory and cognitive functions
A new study in mice has made a possible breakthrough in Alzheimer’s research. The team of researchers at the Cleveland Clinic has noted that deleting a single enzyme can reverse the deposition of harmful plaques in the brains of patients with Alzheimer’s disease. This could improve cognitive functions as demonstrated in lab mice. The study appeared this week in the latest issue of the Journal of Experimental Medicine.
News Medical Life Sciences, 2018-02-18 03:51:54

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

PHAT Life: Effective HIV intervention for youth in the criminal justice system
Program showed great potential for reducing sexual risk-taking.
National Institutes of Health, 2018-02-16 22:30:00

Novartis is preparing to sell its U.S. generics pills business: Reuters
Novartis' new CEO, Vasant Narasimhan, has indicated that the company might spin off its struggling U.S. generic pill business—and that is what it is preparing to do, sources are telling Reuters.
Fierce Pharma, 2018-02-16 16:41:23

Pfizer's Bavencio flops third key study, this time in lung cancer. Can crossover really explain it?
Pfizer and Merck KGaA have suffered another setback with immuno-oncology med Bavencio—and this one’s raising some eyebrows.
Fierce Pharma, 2018-02-16 16:39:53

FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant
Pfizer said several weeks ago that the FDA had updated the status of its troubled Kansas fill-finish plant, paving the way for drug approvals, and sure enough this week Novartis announced an FDA nod for its Copaxone generic being produced there. But a recently released document from the last inspection of the plant shows it continues to struggle, even repeating issues the FDA pointed out in a previous visit.
Fierce Pharma, 2018-02-16 16:12:52

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Neurology-focused Biogen and UCB are already rumored to be eyeing an Acorda buyout. But one analyst thinks a host of other major players could join their ranks.
Fierce Pharma, 2018-02-16 15:18:58

Resolving Interfacial Protein Dynamics by STReM
STReM stands for Super Time-Resolved Microscopy, and as STORM, PALM, and other methods are designed to improve spatial resolution of optical microscopy, we desire to improve the time resolution. STReM makes use of point spread function engineering to encode fast events into each camera frame.
News Medical Life Sciences, 2018-02-16 15:18:00

Study provides new insights on why healthy children die from flu
With this year's severe flu season, one statistic is especially chilling. Each year, around 50 percent of all children under 5 years old who die from the flu were previously healthy, according to the Centers for Disease Control and Prevention (CDC).
News Medical Life Sciences, 2018-02-16 15:16:24

Nature paper unveils bacterial division
The process that allows bacteria to divide is crucial for their survival and a good target for the development of new antibiotics.
News Medical Life Sciences, 2018-02-16 15:13:03